The non-mechanical micropump segment by product type is estimated to lead the market growth during the forecast period.

According to a new market research study of “Europe Micropump Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product, Material, Application, End User and Country.” The Europe micropump market is expected to reach US$ 1,288.56 million by 2028 from as estimated value of US$ 399.12 million in 2021; it is likely to grow at a CAGR of 18.2% from 2021 to 2028. The report highlights trends prevailing in the Europe micropump market and the factors driving market along with those that act as hindrances. 

In the last few years, the pharmaceuticals industry witnessed the introduction of various innovative interventions for the treatment of several chronic diseases. However, most of the available treatment options require parenteral drug administration, frequent dosing, and repeated hospital visits. These are found to be the primary factors negatively affecting medication adherence, thereby impacting therapeutic outcomes. Over the years, several companies have developed advanced therapeutic delivery solutions to overcome the challenges associated with the administration of viscous and large molecule drugs. Microfluidic technologies are evolving to offer a great range of applications and have emerged as a promising application in Point of Care (POC) testing for disease diagnosis. POC tests have the potential to improve disease diagnosis at early stages, as well as offer easy monitoring and increased personalization. Micropumps are key components of microfluidic systems with applications ranging from biological fluid handling to microelectronic cooling, and the objective of integration is to fulfill the need for accurate delivery of fluids. These benefits are utilized for the development of diagnosis and detection POC devices for a variety of conditions such as cancer and infectious diseases. Hence, the integration of microfluidics has advanced the improvisation of POC diagnostics, thereby driving the growth of the micropumps market during the forecast period.

The COVID-19 pandemic in Europe has negatively affected the medical device industry. Various companies have shut down their productions and are unable to meet the rising demand. The dependency on suppliers from other countries also led to several medical companies not being able to meet the demand for medical and personal protective equipment. Additionally, in Europe, many of the micropumps development companies have been directed to develop COVID-19 vaccine. Therefore, it is expected that the growth of the market is likely to be slower in the following few years.

The Europe micropump market, by product type is segmented into mechanical micropump, syringe pump, piezoelectric micropump, peristaltic pump, and non-mechanical micropump. The Europe micropump market based on material is segmented into silicon, polymer, and glass. The Europe micropump market by application, is segmented into medical equipment & devices, clinical & analytical lab, pharmaceuticals, biotechnology, and others. The Europe micropump market by end user, is segmented into hospitals & diagnostic centers, biotechnology & pharmaceutical companies, and academic & research institutes. Geographically, the Europe micropump market can be sub-segmented into UK, Germany, France, Italy, Spain and Rest of Europe.

Advanced Microfluidics, Microfluidica, LLC, Alldoo Micropump Co.,Ltd, Servoflo Corporation, TOPS INDUSTRY AND TECHNOLOGY CO. LTD, World Precision Instruments, Xavitech, Calon Cardio-Technology Ltd, Takasago Electric, Inc. and Medtronic are among the leading companies operating in the Europe micropump market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com